Sartorius Group North America

Sartorius Group North America
Share

Goettingen, Germany, January 4, 2018 – Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S. Abzena has selected Sartorius Stedim to equip its integrated CDMO facilities in...

Sartorius Group North America

 •  December 7, 2017

SIMCA® and SIMCA®-online software updates in the UmetricsTM Suite help manufacturing industries make better business decisions and optimize process control a leading international supplier for the biopharmaceutical industry, has introduced a new version of its SIMCA® and SIMCA®-online data analytical solutions, which are offered by its subsidiary...

Sartorius Group North America

 •  September 28, 2017

Biopharma equipment supplier builds laboratory and office facility at Science Park III in Ulm, Germany Cell Culture Technology Center will cost around 30 million euros Goettingen/Ulm, Germany, September 28, 2017 – Sartorius Stedim Cellca is building a new 30-million-euro Cell Culture Technology Center at Science Park III in Eselsberg situated at...

Sartorius Group North America

 •  September 13, 2017

•New building covering approx. 25,000 square meters •The largest single investment of Sartorius Campus totaling around 42 million euros •Building protected by special construction against vibration Goettingen, Germany, September 13, 2017 – With its new facility for the manufacture of laboratory instruments, Sartorius provides high-quality...

Sartorius Group North America

 •  June 26, 2017

Goettingen, Germany / Malmö, Sweden – June 26, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, has launched the Active Dashboard 2, an advanced software solution. Offered by its subsidiary, Sartorius Stedim Data Analytics, formerly known as Umetrics, the release features significant...

Sartorius Group North America

 •  May 17, 2017

• Firms combine ambr® technology with the BioProfile® FLEX • Unique tool will allow massive quantities of cell culture data to be collected during upstream processing QbD studies Goettingen, GER – May 17, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier to the biopharmaceutical industry, today announced an agreement with Nova...

Unique system offers collection of massive quantities of cell culture data QbD studies in upstream processing more rapidly performed On show for the first time at Cell Line Development & Engineering in San Diego Goettingen, Germany – June 5, 2017: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry,...

Sartorius Group North America

 •  March 3, 2017

Unique cell analysis platform for basic research and drug discovery has broad and expanding user base Acquisition to significantly enhance Sartorius’ Bioanalytics portfolio Goettingen, March 3, 2017 – Sartorius, a leading partner to the biopharmaceutical industry and laboratories, today signed an agreement to acquire U.S. based Essen BioScience...

Sartorius Group North America

 •  January 17, 2017

With its unique portfolio, Sartorius Stedim Biotech supports mainstream adoption of QbD principles by the biopharmaceutical industry. Unique technology portfolio enables design space characterization, effective translation to the large-scale and enhanced process analytics Goettingen, Germany / Aubagne, France, January 18, 2017 – Sartorius Stedim...

Sartorius Group North America

 •  January 2, 2017

Aubagne, July 6, 2016 – Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, today has signed a contract to acquire U.S. centrifuge specialist kSep Holdings, Inc. (kSep). The privately owned company based in Morrisville, North Carolina, has been operating on the market since 2011, and is expected to...